In this short, practical walkthrough, Mark Kaufmann, MD, breaks down what buy and bill really looks like in today’s dermatology landscape, and why it’s worth reconsidering as reimbursements tighten. He explains how the model works, why biologics are often the best place to begin, and how bringing the full drug lifecycle in-house can streamline care, shorten wait times, and stabilize practice revenue.
Dr Kaufmann highlights the essentials: choosing the right medications, understanding which payers permit buy and bill, preparing for cash-flow demands, maintaining tight inventory controls, and documenting with precision. He also underscores the infrastructure required—clear staff roles, accurate coding, and periodic auditing to ensure financial viability.
A grounded, concise guide to when buy and bill makes sense, and how a practice can implement it with confidence.